News
Cambridge Cognition Secures £1million Contract for Phase 3 Autoimmune Disease Trial Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback